State Street Corp Cytokinetics Inc Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 6,085,001 shares of CYTK stock, worth $218 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,085,001
Previous 6,167,340
1.34%
Holding current value
$218 Million
Previous $290 Million
15.7%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding CYTK
# of Institutions
399Shares Held
128MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$527 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$425 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$357 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$287 Million0.06% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.07MShares$110 Million4.32% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.38B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...